Mesotherapy With Bicalutamide: A New Treatment for Androgenetic Alopecia

    Alba Gomez-Zubiaur, JuanJose Andres-Lencina, Víctor Cabezas, Cristina Corredera, Fabio di Brisco, Blanca Ferrer, Ana Rodriguez-Villa, Daniela Subiabre-Ferrer, Cristian Valenzuela, DavidVega Diez, JoseMaria Ricart
    From the encyclopedia
    Bicalutamide →

    a nonsteroidal anti-androgen, most commonly used orally for women

    Mesotherapy →

    technique to inject very small amounts of beneficial chemicals into the scalp

    Studysummary This study found that bicalutamide mesotherapy resulted in subtle hair density improvements and was well tolerated by premenopausal women with androgenetic alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results